Silexion Therapeutics Reports Second Quarter 2026 Financial Results And Provides Business Update - SLXN News | RalliesSilexion Therapeutics Reports Second Quarter 2026 Financial Results And Provides Business Update
S
SLXN• Company update
- Silexion Therapeutics reports second quarter 2026 financial results and provides business update.
M
NYLI CBRE Global Infrastructure Megatrends Term Fund sets monthly distribution at $0.125 per share for August 2026
MEGI•
